Skip to main content

Biliary Tract Cancer clinical trials at UCSF

5 in progress, 2 open to eligible people

Biliary tract cancer is when harmful cells grow in the bile ducts. UCSF is studying a drug mix, CTX-009 and Paclitaxel, for patients with advanced biliary tract cancers. Another trial is testing the safety and effects of Belzutifan with Pembrolizumab and Lenvatinib on solid tumors.

Showing trials for

Our lead scientists for Biliary Tract Cancer research studies include .

Last updated: